News | December 29, 2009

Cardiovascular MR Differentiates Ischemic, Non-Ischemic Injuries

Cardiovascular magnetic resonance (CMR) study.

December 29, 2009 - In patients with known or suspected myocardial infarction, cardiovascular magnetic resonance (CMR) provides a comprehensive, multifaceted view of the heart, according to a study published in the Dec. 29, 2009 to Jan. 5, 2010 issue of Journal of the American College of Cardiology.

Kim and colleagues review the data, which indicate that delayed enhancement (DE)-CMR is a well-validated, robust technique. Because DE-CMR can differentiate between ischemic and various nonischemic forms of myocardial injury, it is especially useful when there is diagnostic uncertainty. Furthermore, CMR provides clinically relevant information, such as residual viability, microvascular damage, stunning, and right ventricular infarction. Because quantification of infarct size by DE-CMR is highly reproducible, it may provide a useful surrogate end point for clinical trials.

Source: Kim, H.; Farzaneh-Far, A.; Kim, R. "Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications." Journal of the American College of Cardiology. Dec. 29, 2009/Jan. 5, 2010. Vol. 55, No. 1

For more information: content.onlinejacc.org

Related Content

Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI)| January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI)| December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI)| December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Overlay Init